Boston Scientific TheraSphere™ Y-90 Glass Microspheres
TheraSphere™ Y-90 Glass Microspheres Late Breaking Data
EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy.
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
- Go to the previous page
- 1
- …
- 428
- 429
- 430
- 431
- 432
- 433
- 434
- …
- 590
- Go to the next page